Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
OrthoSpineNews
JULY 30, 2025
since 2009; data from independent studies performed outside the U.S. Nasdaq: ANIK), a global leader in osteoarthritis pain management and regenerative solutions, today announced topline results from its U.S. with multiple clinical trials demonstrating its safety and effectiveness. Hyalofast has been used outside the U.S.
Let's personalize your content